ParlInfo - CSL-UQ vaccine more 'robust' than fast rivals

Permalink Prev Next Return to results list (1 results)

Date: 08-12-2020
Source: Australian Financial Review
Parl No.
Abstract
Author: REDRUP, Yolanda
Citation Id: 7689103
Cover date: 8 December, 2020
Enrichment
Item
Key item: No
Major subject: COVID-19
Vaccines
Medical research
CSL
University of Queensland
Pharmaceutical industry
Capital investment
Antiviral drugs
Severe Acute Respiratory Syndrome
Immunisation
Minor subject
MP: no
Pages
Party
Speech
Text online: yes
Venue
System Id: media/pressclp/7689103

Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document

Menu Options